Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications

Nature Reviews. Drug Discovery
Hsin-Pei ShihAlex M Aronov

Abstract

The productivity of the pharmaceutical industry has been widely discussed in recent years, particularly with regard to concerns that substantial expenditures on research and development have failed to translate into approved drugs. Various analyses of this productivity challenge have focused on aspects such as attrition rates at particular clinical phases or the physicochemical properties of drug candidates, but relatively little attention has been paid to how the industry has performed from the standpoint of the choice of therapeutic mechanisms and their intended indications. This article examines what the pharmaceutical industry has achieved in this respect by analysing comprehensive industry-wide data on the mechanism-indication pairs that have been investigated during the past 20 years. Our findings indicate several points and trends that we hope will be useful in understanding and improving the productivity of the industry, including areas in which the industry has had substantial success or failure and the relative extent of novelty in completed and ongoing projects.

References

Mar 1, 1988·British Journal of Clinical Pharmacology·R A PrentisS R Walker
Jan 8, 1997·JAMA : the Journal of the American Medical Association·S G DeeksJ O Kahn
Jan 1, 1997·AIDS Clinical Review·S G Deeks, P A Volberding
Feb 5, 2000·Stroke; a Journal of Cerebral Circulation·S M DavisJ Norris
Apr 13, 2001·JAMA : the Journal of the American Medical Association·R L SaccoUNKNOWN Glycine Antagonist in Neuroprotection Americas Investigators
Dec 26, 2001·JAMA : the Journal of the American Medical Association·G W AlbersUNKNOWN Aptiganel Acute Stroke Investigators
Feb 4, 2003·Nature Reviews. Drug Discovery·Lars OlbePer Lindberg
Apr 2, 2003·Expert Opinion on Therapeutic Targets·Peter Traxler
Jul 10, 2003·Lancet Neurology·Chrysanthy Ikonomidou, Lechoslaw Turski
Mar 23, 2004·Current Molecular Medicine·L HoyteM D Hill
May 4, 2004·Nature Reviews. Cancer·Andreas GschwindAxel Ullrich
Jun 9, 2004·Current Opinion in Chemical Biology·Daniel B Kassel
Aug 3, 2004·Nature Reviews. Drug Discovery·Ismail Kola, John Landis
Nov 19, 2004·The New England Journal of Medicine·F Estelle R Simons
Sep 8, 2005·Expert Opinion on Investigational Drugs·Nathalie Goudreau, Montse Llinàs-Brunet
Dec 20, 2005·Current Opinion in Pharmacology·Keith W Muir
Mar 24, 2006·The New England Journal of Medicine·Steven E NissenUNKNOWN ACAT Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Investigators
Oct 17, 2006·Expert Opinion on Investigational Drugs·John R Burnett, Murray W Huff
Jun 30, 2007·Nature Reviews. Drug Discovery·Menelas N PangalosOrest Hurko
Jul 11, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Stefan S De BuckRon A H J Gilissen
Dec 18, 2007·Pharmacology & Therapeutics·Christopher J LangmeadCharlie Reavill
Mar 15, 2008·Nature Reviews. Drug Discovery·Chris JensenHans Rudolf Brunner
Mar 13, 2009·The AAPS Journal·Hannah M JonesKenny J Watson
Mar 19, 2009·JAMA : the Journal of the American Medical Association·Marijn C MeuweseUNKNOWN CAPTIVATE Investigators
Jul 16, 2009·Current Pharmaceutical Design·Jianling Wang
Feb 5, 2010·Clinical Pharmacology and Therapeutics·J A DiMasiA Wilson
Feb 20, 2010·Nature Reviews. Drug Discovery·Steven M PaulAaron L Schacht
Feb 26, 2010·Expert Opinion on Therapeutic Patents·Carlo Pergola, Oliver Werz
Apr 7, 2010·Nature Reviews. Drug Discovery·William N Hait
Jun 10, 2010·Nature Reviews. Drug Discovery·M Miles BraunTimothy R Coté
May 3, 2011·Nature Reviews. Drug Discovery·John Arrowsmith
May 19, 2011·Nature Chemical Biology·Mark E Bunnage
Jun 2, 2011·Nature Reviews. Drug Discovery·Fabio PammolliMassimo Riccaboni
Aug 20, 2011·Nature Reviews. Drug Discovery·Eric KarranBart De Strooper
Mar 1, 2012·Drug Discovery Today·Kiran N MeekingsJohn E Arrowsmith
Mar 2, 2012·Nature Reviews. Drug Discovery·Jack W ScannellBrian Warrington
Mar 31, 2012·Nature Reviews. Drug Discovery·Irena Melnikova
Dec 1, 2012·Nature Reviews. Drug Discovery·Joanne BowesSteven Whitebread
Dec 4, 2012·Mini Reviews in Medicinal Chemistry·Palash PalMange Ram Yadav
Jul 3, 2013·Biochemical Pharmacology·Paul McGonigle
Jul 23, 2013·Nature Reviews. Drug Discovery·Robert M PlengeDavid Altshuler
Aug 2, 2013·Nature Reviews. Drug Discovery·John Arrowsmith, Philip Miller
Aug 2, 2013·Nature Reviews. Drug Discovery·Pankaj AgarwalLon R Cardon
Oct 5, 2013·Expert Opinion on Therapeutic Targets·Antonio Di Gennaro, Jesper Z Haeggström
Oct 19, 2013·Nature Reviews. Drug Discovery·Michael RingelUlrik Schulze

❮ Previous
Next ❯

Citations

Feb 24, 2018·Nature Reviews. Drug Discovery·Tudor I OpreaGergely Zahoránszky-Köhalmi
Oct 16, 2018·Expert Opinion on Drug Discovery·Michael RonzettiAnton Simeonov
Jan 16, 2019·Chemistry, an Asian Journal·Zsuzsa SárkányPedro M Martins
May 24, 2019·Journal of Cellular and Molecular Medicine·Marien J C HoutmanMarcel A G van der Heyden
Aug 27, 2019·Medicinal Research Reviews·Rui ChenKhaled Barakat
May 12, 2019·Scientific Reports·Maria Ryaboshapkina, Mårten Hammar
Aug 10, 2020·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Cristina AltrocchiPaul G A Volders
Mar 17, 2020·Archives of Dermatological Research·Cervantes-Durán ClaudiaGarcía-Pérez Martha-Estrella
May 30, 2019·International Journal of Molecular Sciences·Tristan O C KwanIsabel Moraes
Jun 7, 2020·Nature Communications·Rhythm ShuklaMarkus Weingarth
Jul 14, 2018·Nature Communications·Feixiong ChengJoseph Loscalzo
Dec 13, 2019·Scientific Reports·Aroon D HingoraniJuan Pablo Casas
Jul 31, 2020·British Journal of Cancer·Ross J PorterMairi H McLean
Oct 27, 2020·Computational and Structural Biotechnology Journal·Ekaterina ShevchenkoTatu Pantsar
Feb 12, 2020·Seminars in Cancer Biology·Vinayak PalveUwe Rix
Dec 1, 2019·Drug Discovery Today. Technologies·Jie Shen, Christos A Nicolaou
Nov 27, 2019·Journal of Cheminformatics·Fan WangGuang-Fu Yang
Jan 24, 2021·Drug Discovery Today·Sophia Malandraki-Miller, Paul R Riley
Jan 30, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Guangxu XiaoYan Zhu
Apr 9, 2021·Clinical and Translational Science·Shingo YamaguchiMamoru Narukawa
May 14, 2021·Journal of Medicinal Chemistry·Paul D LeesonAndrew R Leach
May 25, 2021·ELife·Anton BespalovThomas Steckler
Jul 3, 2021·Cancers·Christina PfabNahed El-Najjar
Jul 7, 2021·Drug Discovery Today·Alexander SchuhmacherDominik Hartl
Aug 8, 2019·Biochemistry·Edoardo FabiniU Helena Danielson
Jun 13, 2019·Journal of Medicinal Chemistry·Yan A IvanenkovVladimir A Aladinskiy
Nov 6, 2018·Chemical Reviews·Yichao HuangHiroaki Suga
Jul 31, 2021·Chemistry : a European Journal·David J FallonJacob T Bush
Aug 25, 2021·Pharmacotherapy·Tammy H CummingsS Scott Sutton
Sep 28, 2021·Journal of the American Chemical Society·Emily R WearingCorinna S Schindler
Sep 25, 2021·British Journal of Clinical Pharmacology·Heleen MarynissenJan de Hoon
Oct 16, 2021·Cold Spring Harbor Perspectives in Medicine·Amand F SchmidtChris Finan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.